ReACT Therapeutics Breaking the Cancer Resistance Barrier Cancer therapeutics In vitro, proof of concept France Status Approved IP Type Patent...
Cancer therapeutics
NeoTargets We offer a unique approach to significantly de-risk drug discovery through several proprietary methodologies Cancer Therapeutics In vitro, proof...
Nanobots Therapeutics Unique therapeutic entities that penetrate tissues with superior efficacy, enhancing drug accumulation in target cells Cancer therapeutics In...
Kairos Discovery Kairos Discovery develops small molecules targeting protein kinases to treat cancer Cancer therapeutics Prototyping, preclinical France 1.500.000€ Status...
Aptadel Therapeutics A biotech company developing RNA technologies for the treatment of childhood cancer Cancer therapeutics Prototyping, preclinical Spain 1.500.000€...
Hemerion Therapeutics Advancing cancer therapies. At the speed of light. Cancer therapeutics Development, market readiness, clinical trial France 2.000.000€ Status...
Inti Biotech Explore the next frontier in advanced cancer therapy: Microgravity Cancer therapeutics Prototyping, preclinical Canada 3.000.000$ Status - IP...
Ability Pharmaceuticals AbilityPharma is a late stage company developing clinically (Phase 2) an oral targeted anti-cancer drug (ABTL0812) Cancer therapeutics...
IBIONS
Heidi Rohwer, , 0IBIONS IBIONS: Personalized Nutrition meets AI for a healthier tomorrow, revolutionizing cancer care one bite at a time Cancer therapeutics...